JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

VEGFR

A3843 SU 5402
4 Citation

Target: VEGFR|PDGFR|FGFR

Summary: VEGFR2/FGFR/PDGFR/EGFR inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.8 mg/mL
A3751 Regorafenib monohydrate

Summary: Tyrosine kinase inhibitor

≥25.05 mg/mL
A3750 Regorafenib hydrochloride

Target: Raf|VEGFR|PDGFR|c-Kit|c-RET

Summary: Tyrosine kinase inhibitor

≥25.95 mg/mL
A3022 Pazopanib (GW-786034)

Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFR

Summary: VEGFR/PDGFR/FGFR inhibitor

insoluble in EtOH; insoluble in H2O; ≥10.95 mg/mL
A3009 Sorafenib
2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
A2974 Foretinib (GSK1363089)
1 Citation

Summary: VEGF and HGF receptor inhibitor

≥31.65 mg/mL
A2949 Linifanib (ABT-869)

Target: VEGFR|PDGFR

Summary: VEGFR/PDGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.75 mg/mL
A2633 Brivanib Alaninate (BMS-582664)

Summary: VEGFR2 inhibitor,ATP-competitive

≥22.05 mg/mL
A2597 Brivanib (BMS-540215)

Target: VEGFR|FGFR|Flk1

Summary: VEGFR-2 inhibitor,ATP-competitive

insoluble in H2O; ≥18.5 mg/mL
A2251 Tivozanib (AV-951)

Target: VEGFR

Summary: VEGFR inhibitor,potent and selective

≥22.75 mg/mL